DXR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DXR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Daxor's Trailing 12-Month Free Cash Flow is $0.03 Mil, and Market Cap is $39.97 Mil. Therefore, Daxor's FCF Yield % for today is 0.07%.
The historical rank and industry rank for Daxor's FCF Yield % or its related term are showing as below:
During the past 13 years, the highest FCF Yield % of Daxor was 64.28%. The lowest was -10.18%. And the median was -2.36%.
Daxor's FCF Margin % for the quarter that ended in Dec. 2024 was 27.29%.
The historical data trend for Daxor's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daxor Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
FCF Yield % | Get a 7-Day Free Trial |
![]() |
![]() |
-4.85 | -6.05 | -1.96 | -7.92 | 0.07 |
Daxor Semi-Annual Data | ||||||||||||||||||||
Jun15 | Dec15 | Jun16 | Dec16 | Jun17 | Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | Dec24 | |
FCF Yield % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-1.44 | -12.49 | -3.39 | -3.96 | 4.85 |
For the Medical Instruments & Supplies subindustry, Daxor's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Daxor's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Daxor's FCF Yield % falls into.
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Daxor's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as
FCF Yield % | = | Free Cash Flow | / | Market Cap |
= | 0.026 | / | 37.94246 | |
= | 0.07% |
Daxor's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as
FCF Yield % | = | Free Cash Flow | * | Annualized Factor | / | Market Cap |
= | 0.92 | * | 2 | / | 37.94246 | |
= | 4.85% |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daxor FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Thank you for viewing the detailed overview of Daxor's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Robert J Michel | officer: CHIEF FINANCIAL OFFICER | C/O ASTA FUNDING, INC., 210 SYLVAN AVENUE, ENGLEWOOD CLIFFS NJ 07632 |
Michael Richard Feldschuh | director | 71 GRAND STREET #2, NEW YORK NY 10013 |
Edward Feuer | director | 2 WALL STREET, 10TH FLOOR, NEW YORK NY 10005 |
Joy S. Goudie | director | 350 FIFTH AVENUE, SUITE 4740, NEW YORK NY 10118 |
Caleb Desrosiers | director | DAXOR CORPORATION, 109 MECO LANE, OAK RIDGE TN 37830 |
Henry D. Cremisi | director | 350 FIFTH AVENUE, SUITE 4740, NEW YORK NY 10118 |
Soren Thompson | officer: V.P./BUSINESS DEVELOPMENT | 180 CENTRAL PARK SOUTH, APT. 805, NEW YORK NY 10019 |
Jonathan Adam Feldschuh | director, officer: CHIEF SCIENTIFIC OFFICER | DAXOR CORPORATION, 350 5TH AVENUE, SUITE 4740, NEW YORK NY 10118 |
Joseph Feldschuh | officer: President | 615 W. 252ND STREET, BRONX NY 10471 |
Estate Of Joseph Feldschuh | other: FOUNDER | 350 FIFTH AVENUE, SUITE 4740, NEW YORK NY 10118 |
Diane Marie Meegan | officer: Corporate Secretary | 259 NEW YORK AVENUE, JERSEY CITY NJ 07307 |
Bernhard Saxe | director | 6805 WILD ROSE COURT, SPRINGFIELD VA 25152 |
Robert Willens | director | 200 EAST 74TH ST APT 18C, NEW YORK NY 10021 |
Philip Nordan Hudson | director | P.O. BOX 160892, SAN ANTONIO TX 78280-3092 |
Everis Engstrom | officer: Vice President | 3244 BLACK FOX ROAD, WASHBURN TN 37888 |
From GuruFocus
By Marketwired • 06-18-2024
By Marketwired • 09-27-2024
By Marketwired • 04-10-2024
By Marketwired • 04-15-2024
By Marketwired • 08-05-2024
By Marketwired • 03-04-2025
By Marketwired • 03-04-2025
By Marketwired • 04-16-2024
By Marketwired • 02-18-2025
By Marketwired • 02-13-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.